tetradecanoylphorbol acetate and mdv 3100

tetradecanoylphorbol acetate has been researched along with mdv 3100 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dejima, T; Inokuchi, J; Itsumi, M; Kashiwagi, E; Naito, S; Shiota, M; Takeuchi, A; Tatsugami, K; Uchiumi, T; Yokomizo, A	1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and mdv 3100

Article	Year
PMA induces androgen receptor downregulation and cellular apoptosis in prostate cancer cells. Journal of molecular endocrinology, 2014, Volume: 53, Issue:1 Topics: Androgen Receptor Antagonists; Antineoplastic Agents; Apoptosis; Benzamides; Cell Line, Tumor; Down-Regulation; Drug Resistance, Neoplasm; E2F1 Transcription Factor; Gene Knockdown Techniques; Humans; Male; MAP Kinase Signaling System; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Protein Kinase C; Receptors, Androgen; Signal Transduction; Tetradecanoylphorbol Acetate; Tumor Suppressor Protein p53	2014

Article

Year

PMA induces androgen receptor downregulation and cellular apoptosis in prostate cancer cells.

Journal of molecular endocrinology, 2014, Volume: 53, Issue:1

Topics: Androgen Receptor Antagonists; Antineoplastic Agents; Apoptosis; Benzamides; Cell Line, Tumor; Down-Regulation; Drug Resistance, Neoplasm; E2F1 Transcription Factor; Gene Knockdown Techniques; Humans; Male; MAP Kinase Signaling System; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Protein Kinase C; Receptors, Androgen; Signal Transduction; Tetradecanoylphorbol Acetate; Tumor Suppressor Protein p53

2014